This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2000 Nov 4;356(9241):1536-7.

doi: 10.1016/S0140-6736(00)03117-2.

Treatment of aplastic anaemia: first do no harm

J C Marsh¹

Affiliations

PMID: 11075760
DOI: 10.1016/S0140-6736(00)03117-2

Comment

Treatment of aplastic anaemia: first do no harm

J C Marsh. Lancet. 2000.

. 2000 Nov 4;356(9241):1536-7.

doi: 10.1016/S0140-6736(00)03117-2.

Author

J C Marsh¹

Affiliation

¹ Department of Haematology, St George's Hospital Medical School, London, UK.

PMID: 11075760
DOI: 10.1016/S0140-6736(00)03117-2

No abstract available

PubMed Disclaimer

Comment on

High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial.
Tisdale JF, Dunn DE, Geller N, Plante M, Nunez O, Dunbar CE, Barrett AJ, Walsh TJ, Rosenfeld SJ, Young NS. Tisdale JF, et al. Lancet. 2000 Nov 4;356(9241):1554-9. doi: 10.1016/S0140-6736(00)03126-3. Lancet. 2000. PMID: 11075769 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information